MS

Meesala Sai Bhakta Chalapathi Rao

Director DIN 01764287
DIN 01764287 First appointment Sep 2005
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Meesala Sai Bhakta Chalapathi Rao

Data last updated:

Meesala Sai Bhakta Chalapathi Rao was a Director at Symetric Life Sciences India Private Limited (from 2013) and Director at Sristek Clinical Research Solutions Limited (from 2005).

DIN 01764287
First Appointment 14 Sep 2005
Oldest Company Age 24 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 May 20132013Strike Off
Director14 Sep 20052002Dissolved (Liquidated)

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Symetric Life Sciences India Private Limited
Sristek Clinical Research Solutions Limited
Premium access

Shareholding and investment profile for Meesala Sai Bhakta Chalapathi Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meesala Sai Bhakta Chalapathi Rao

Meesala Sai Bhakta Chalapathi Rao was first appointed on 14 Sep 2005 as Director at Sristek Clinical Research Solutions Limited. The most recent appointment on record is 24 May 2013 at Symetric Life Sciences India Private Limited.

Meesala Sai Bhakta Chalapathi Rao held 2 earlier board appointments: Symetric Life Sciences India Private Limited (Director, from 24 May 2013); Sristek Clinical Research Solutions Limited (Director, from 14 Sep 2005).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available